Development of an adenovirus vector vaccine platform for targeting dendritic cells
Development of an adenovirus vector vaccine platform for targeting dendritic cells
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Adenoviral (Ad) vector vaccines represent one of the most promising modern vaccine platforms, and Ad vector vaccines are currently being investigated in human clinical trials for infectious disease and cancer. Our studies have shown that specific targeting of adenovirus to dendritic cells dramatically enhanced vaccine efficacy. However, this was ac...
Alternative Titles
Full title
Development of an adenovirus vector vaccine platform for targeting dendritic cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5972836
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5972836
Other Identifiers
ISSN
0929-1903
E-ISSN
1476-5500
DOI
10.1038/s41417-017-0002-1
